Monogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The Company is Preparing for Commercialization and Evaluating ...
Acquisition expected to be neutral to adjusted earnings per share in 2025 – 2027 and accretive thereafter and to contribute to revenue growth beginning in 2027 Monogram’s semi- and fully autonomous ...
Zimmer Biomet Holdings, Inc. has announced its acquisition of Monogram Technologies Inc. for $4.04 per share in cash, totaling approximately $177 million in equity value. This acquisition will create ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback